Table 3 Parasitological status, weight status and oral health status of children in intervention schools and control schools in Cambodia, Indonesia, Lao PDR and the pooled regional countries at baseline and follow-up
Cambodia | Indonesia | Lao PDR | Regional (pooled) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FIT | Control | P* | FIT | Control | P* | FIT | Control | P* | FIT | Control | P* | |
Parasitological status | ||||||||||||
STH-prevalence at baseline (n, %) | 22 (9.1) | 18 (7.7) | 0.573 | 3 (1.5) | 6 (3.0) | 0.298 | 25 (9.9) | 37 (15.6) | 0.059 | 50 (7.1) | 61 (9.1) | 0.195 |
STH-prevalence at follow-up (n, %) | 34 (15.9) | 14 (9.1) | 0.056 | 2 (1.0) | 6 (3.1) | 0.120 | 22 (8.4) | 25 (10.6) | 0.419 | 58 (8.4) | 45 (7.7) | 0.630 |
Weight status | ||||||||||||
Prevalence of thinness at baseline (n, %) | 21 (8.9) | 23 (9.9) | 0.718 | 15 (6.1) | 25 (10.6) | 0.076 | 16 (5.9) | 19 (7.6) | 0.434 | 52 (7.5) | 67 (9.9) | 0.112 |
Prevalence of thinness at follow-up (n, %) | 31 (13.2) | 36 (15.5) | 0.485 | 14 (5.7) | 23 (9.7) | 0.095 | 25 (9.1) | 21 (8.3) | 0.748 | 70 (10.7) | 80 (12.5) | 0.294 |
Oral health status (permanent dentition)a | ||||||||||||
Dental caries prevalence at baseline (n, %) | 32 (13.3) | 43 (18.1) | 0.149 | 26 (10.6) | 23 (9.7) | 0.741 | 36 (15.7) | 40 (18.9) | 0.382 | 94 (13.1) | 106 (15.4) | 0.223 |
Dental caries prevalence at follow-up (n, %) | 126 (52.7) | 137 (58.1) | 0.243 | 75 (30.5) | 83 (35.0) | 0.288 | 68 (29.8) | 80 (38.3) | 0.062 | 269 (37.7) | 300 (44.0) | 0.017 |
Prevalence of PUFA at baseline (n, %) | 1 (0.4) | 3 (1.3) | 0.3701 | 0 (0.0) | 0 (0.0) | - | 1 (0.4) | 5 (2.4) | 0.1101 | 2 (0.3) | 8 (1.2) | 0.0601 |
Prevalence of PUFA at follow-up (n, %) | 17 (7.1) | 23 (9.8) | 0.302 | 21 (8.6) | 18 (7.6) | 0.704 | 10 (4.4) | 16 (7.7) | 0.149 | 48 (6.7) | 57 (8.4) | 0.265 |
DMFT at baseline (mean ± sd) | 0.18 ± 0.51 | 0.30 ± 0.73 | 0.127 | 0.15 ± 0.50 | 0.13 ± 0.44 | 0.757 | 0.28 ± 0.78 | 0.37 ± 0.90 | 0.324 | 0.20 ± 0.61 | 0.26 ± 0.71 | 0.181 |
DMFT at follow-up (mean ± sd) | 1.00 ± 1.20 | 1.29 ± 1.49 | 0.066 | 0.50 ± 0.92 | 0.59 ± 0.96 | 0.257 | 0.54 ± 1.06 | 0.79 ± 1.28 | 0.026 | 0.68 ± 1.09 | 0.89 ± 1.29 | 0.003 |
DMFT increment (mean ± sd) | 0.82 ± 1.07 | 0.99 ± 1.30 | 0.262 | 0.35 ± 0.72 | 0.46 ± 0.79 | 0.168 | 0.26 ± 0.81 | 0.41 ± 1.11 | 0.373 | 0.48 ± 0.91 | 0.63 ± 1.12 | 0.049 |
PUFA at baseline (mean ± sd) | 0.00 ± 0.06 | 0.02 ± 0.16 | 0.309 | 0.00 ± 0.00 | 0.00 ± 0.00 | - | 0.01 ± 0.13 | 0.02 ± 0.15 | 0.084 | 0.00 ± 0.08 | 0.01 ± 0.13 | 0.049 |
PUFA at follow-up (mean ± sd) | 0.10 ± 0.37 | 0.13 ± 0.42 | 0.312 | 0.13 ± 0.44 | 0.09 ± 0.34 | 0.663 | 0.08 ± 0.47 | 0.11 ± 0.42 | 0.149 | 0.10 ± 0.43 | 0.11 ± 0.40 | 0.267 |
PUFA increment (mean ± sd) | 0.09 ± 0.35 | 0.11 ± 0.38 | 0.483 | 0.13 ± 0.44 | 0.09 ± 0.34 | 0.663 | 0.07 ± 0.39 | 0.09 ± 0.41 | 0.434 | 0.10 ± 0.40 | 0.10 ± 0.38 | 0.548 |
Preventive fraction (DMFT) (%) | 18.3% | 22.4% | 38.0% | 23.9% | ||||||||